文献速递肾血管病与高血压水电解质与酸碱慢性肾脏病

高钾血症与血压调节:WNK信号通路的新进展

Hyperkalemia and blood pressure regulation.
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

本文综述了高钾血症与高血压并存的临床挑战,重点探讨了家族性高钾性高血压(FHHt)综合征作为经典模型,揭示WNK激酶在远端肾单位调控钠钾处理中的关键作用。WNK信号通路通过复杂蛋白网络影响钠钾转运蛋白,从而参与血压调节,靶向WNK或其底物为管理高血压并预防高钾血症提供了有前景的策略。

要点

  • 高钾血症常与慢性肾脏病或RAAS抑制剂、钙调神经磷酸酶抑制剂使用相关。
  • FHHt由WNK激酶活性过高引起,是高血压合并高钾血症的经典模型。
  • WNK信号通路是肾脏适应钾平衡变化的关键调节机制,靶向WNK有望兼顾降压与防高钾。

核心结论

  • WNK信号通路是肾脏钠钾处理的关键调节者,靶向WNK或其底物可能为管理高血压并预防高钾血症提供新策略。

研究设计与样本

  • 本文为综述,总结了WNK信号通路的最新研究进展及肾脏适应高钾血症的现有模型。

主要发现

  • FHHt可由多个基因突变引起,均导致远端肾单位WNK激酶活性过高。
  • WNK信号通路通过复杂蛋白网络介导不同WNK亚型对钠钾转运蛋白的催化与非催化效应。

临床怎么用

  • 对于高钾血症风险的高血压患者,理解WNK通路机制有助于选择兼顾降压与血钾安全的治疗策略。
  • 药理学靶向WNK或其底物是未来管理高血压并预防高钾血症的潜在方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hypertension is common in the general population. Management of hypertensive patients at risk of hyperkalemia is challenging due to potential life-threatening complications such as cardiac arrest. Chronic hyperkalemia is often associated with impaired renal ability to excrete excessive potassium ions (K+). This may refer to chronic kidney disease or certain pharmacological interventions, including broadly used renin-angiotensin-aldosterone system and calcineurin inhibitors. Understanding the intrinsic mechanisms permitting kidney adaptations to hyperkalemia is critical for choosing therapeutic strategies. Valuable insights were obtained from the analysis of familial hyperkalemic hypertension (FHHt) syndrome, which became a classic model for coincidence of high blood pressure and hyperkalemia. FHHt can be caused by mutations in several genes, all of them resulting in excessive activity of with-no-lysine kinases (WNKs) in the distal nephron of the kidney. WNKs have been increasingly recognized as key signalling enzymes in the regulation of renal sodium ions (Na+) and K+ handling, enabling adaptive responses to systemic shifts of potassium homoeostasis consequent to variations in dietary potassium intake or disease. The WNK signalling pathway recruits a complex protein network mediating catalytic and non-catalytic effects of distinct WNK isoforms on relevant Na+- or K+-transporting proteins. In this review article, we summarize recent progress in understanding WNK signalling. An update of available models for renal adaptation to hyperkalemic conditions is presented. Consequences for blood pressure regulation are discussed. Pharmacological targeting of WNKs or their substrates offers promising options to manage hypertension while preventing hyperkalemia.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Mutig K, Bachmann S. Hyperkalemia and blood pressure regulation. Nephrol Dial Transplant. 2019. PMID: 31800077. doi:10.1093/ndt/gfz218

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。